Further information
Dr Robert Strieter, Henry B. Mulholland Professor of Medicine,University of Virginia School of Medicine, Charlottesville, VA, USA, presents the Annual Margaret Turner-Warwick Respiratory Lecture on: “The role of vascular remodeling and fibrocytes in pulmonary fibrosis.”
In the Chair: Professor Peter J. Barnes, Professor of Respiratory Medicine, NHLI, Imperial College London
Vote of Thanks: Professor Athol Wells, Professor of Respiratory Medicine, NHLI, Imperial College London
A tea/coffee reception will precede the lecture at 17.00 and a drinks reception will follow the lecture, both in the Refectory of the Guy Scadding Building.
Abstract: The CXC chemokine family is a pleiotropic family of cytokines that are involved in promoting the trafficking of various leukocytes, in regulating angiogenesis and vascular remodeling, and in promoting the mobilization and trafficking of mesenchymal progenitor cells such as fibrocytes. The function of CXC chemokines are important in the pathogenesis of pulmonary fibrosis and other fibroproliferative disorders. In this presentation, the biology of CXC chemokine family members, specifically as it relates to their role in regulating vascular remodeling and trafficking of circulating mesenchymal progenitor cells (also known as fibrocytes) in pulmonary fibrosis will be discussed.
Biography: Robert M. Strieter, MD, is the Henry B. Mulholland Professor of Medicine and Chair, Department of Medicine, University of Virginia School of Medicine at Charlottesville, Virginia, USA.
Dr. Strieter received his undergraduate degree at University of Michigan and his medical degree at Michigan State University in East Lansing. After completing his internship and residency in Internal Medicine at St. Joseph Mercy Hospital in Ann Arbor, Dr. Strieter performed his fellowship in Pulmonary and Critical Care at the University of Michigan. Dr. Strieter began his career as Lecturer for the Department of Internal Medicine at University of Michigan and rose rank to full professor with tenure in 1996. Dr. Strieter joined the faculty of the David Geffen School of Medicine at UCLA in 2000, as Chief of Pulmonary and Critical Care Medicine and Vice Chair of the Department of Medicine for Hospitalist programs.
Dr. Strieter assumed the position of Chair of the Department of Medicine at the University of Virginia, School of Medicine in 2006. Dr. Strieter’s laboratory focuses on five thematic areas that include lung cancer, pulmonary fibrosis, acute lung injury, lung transplantation, and adult progenitor cell biology. He has focused his research and lectured internationally on cytokine/chemokine biology associated with adult progenitor cell trafficking, angiogenesis, inflammation, and immunologically mediated diseases.
Dr. Strieter is a member of the American Association of Immunologists, American Association for the Advancement of Science, American Thoracic Society, American Federation for Medical Research, American Society for Clinical Investigation, American Association of Physicians, the American Society of Investigative Pathology, and the American Clinical and Climatological Association. He is a Fellow of both the American College of Chest Physicians and the American College of Physicians. He is a Master of the American College of Physicians. Dr. Strieter sits on the editorial boards of five scientific journals, is a reviewer for over 37 journals, and is the co-editor of two books, Chemokines in Disease and Chemokines in the Lung. In addition, he has published over 80 book chapters and 500 peer-reviewed publications in prestigious medical journals. His H-index is 107.
To register for this event please email Emma Watson